HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J P Donnelly Selected Research

Mycoses (Diseases, Fungus)

4/2015A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.
12/2012ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
1/2004The role of itraconazole in preventing and treating systemic fungal infections in immunocompromised patients.
5/2002Symptoms and diagnosis of nosocomial fungal infections -- state-of-the-art.
10/2000Febrile neutropenia: antifungal prophylaxis.
6/2000A strategy for managing fungal infections in haematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J P Donnelly Research Topics

Disease

12Mucositis
04/2014 - 06/2000
9Neutropenia
04/2014 - 01/2001
8Neoplasms (Cancer)
01/2018 - 05/2002
7Aspergillosis
11/2021 - 06/2000
7Infections
03/2012 - 11/2000
6Mycoses (Diseases, Fungus)
04/2015 - 06/2000
5Candidiasis (Moniliasis)
12/2012 - 06/2000
5Fever (Fevers)
09/2011 - 11/2000
4Stomatitis
09/2007 - 04/2004
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 04/2004
3Graft vs Host Disease (Graft-Versus-Host Disease)
02/2014 - 11/2000
3Atrophy
08/2010 - 02/2004
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2013 - 09/2006
2Inflammation (Inflammations)
04/2008 - 11/2000
2Invasive Fungal Infections
11/2007 - 05/2002
1Disease Progression
11/2021
1Bacteremia
04/2014
1Citrullinemia
04/2014
1Thrombosis (Thrombus)
02/2014
1Thrombophlebitis
02/2014
1Febrile Neutropenia
01/2014
1Epstein-Barr Virus Infections
11/2013
1Acquired Immunodeficiency Syndrome (AIDS)
12/2012
1Oral Candidiasis (Thrush)
12/2012
1Anastomotic Leak
12/2012
1Sepsis (Septicemia)
09/2011
1Intestinal Failure
08/2010
1Invasive Candidiasis
04/2009
1Multiple Myeloma
01/2009
1Hematologic Neoplasms (Hematological Malignancy)
04/2008
1Zygomycosis (Phycomycosis)
11/2007
1Necrosis
02/2004
1Bacterial Infections (Bacterial Infection)
11/2000
1Communicable Diseases (Infectious Diseases)
06/2000

Drug/Important Bio-Agent (IBA)

7CitrullineIBA
04/2014 - 08/2004
4C-Reactive ProteinIBA
04/2014 - 11/2000
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2014 - 01/2001
4Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
02/2009 - 01/2001
3Melphalan (Alkeran)FDA LinkGeneric
04/2014 - 01/2009
3Fluconazole (Zonal)FDA LinkGeneric
12/2012 - 12/2012
2Rituximab (Mabthera)FDA Link
11/2013 - 09/2006
2Itraconazole (Sporanox)FDA LinkGeneric
12/2012 - 01/2004
2Voriconazole (Vfend)FDA LinkGeneric
12/2012 - 11/2007
2AzolesIBA
12/2012 - 12/2012
2liposomal amphotericin BFDA Link
12/2012 - 12/2012
2Pharmaceutical PreparationsIBA
12/2012 - 03/2004
2Cytostatic AgentsIBA
09/2007 - 02/2004
2galactomannanIBA
09/2006 - 10/2000
2AntigensIBA
09/2006 - 06/2002
2SugarsIBA
10/2005 - 04/2004
2Biomarkers (Surrogate Marker)IBA
03/2005 - 08/2004
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2004 - 01/2001
1Adenosine Monophosphate (AMP)IBA
11/2021
1TriazolesIBA
01/2018
1AnidulafunginFDA Link
04/2015
1fludarabineIBA
04/2014
1CoagulaseIBA
02/2014
1Fibroblast Growth Factor 7FDA Link
01/2014
1Flucytosine (Ancobon)FDA Link
12/2012
1SolutionsIBA
12/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2012
1Anti-Bacterial Agents (Antibiotics)IBA
09/2011
1Amino AcidsFDA Link
08/2010
1AntibodiesIBA
04/2009
1MannansIBA
04/2009
1LactoferrinIBA
04/2008
1RhamnoseIBA
10/2005
1DipeptidesIBA
10/2005
1Glutamine (L-Glutamine)FDA Link
10/2005
1Lactulose (Duphalac)FDA LinkGeneric
10/2005
1Interleukin-8 (Interleukin 8)IBA
10/2005
1AnthracyclinesIBA
04/2005
1NF-kappa B (NF-kB)IBA
02/2004
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2004
1Methotrexate (Mexate)FDA LinkGeneric
02/2004
1CurcuminIBA
02/2004
1Sodium Glutamate (Accent)IBA
05/2002
1GlycopeptidesIBA
01/2001
1Tobramycin (Nebcin)FDA LinkGeneric
01/2001
1PiperacillinFDA LinkGeneric
01/2001
1Ceftazidime (Fortum)FDA LinkGeneric
01/2001
1ProcalcitoninIBA
11/2000

Therapy/Procedure

13Therapeutics
04/2014 - 01/2001
10Stem Cell Transplantation
02/2014 - 06/2000
9Drug Therapy (Chemotherapy)
01/2018 - 01/2004
5Transplantation
02/2014 - 06/2000
2Catheters
02/2014 - 01/2001
1Artificial Respiration (Mechanical Ventilation)
02/2014
1Highly Active Antiretroviral Therapy (HAART)
12/2012
1Critical Care (Surgical Intensive Care)
12/2012
1Hematopoietic Stem Cell Transplantation
04/2008
1Aftercare (After-Treatment)
11/2007
1Length of Stay
10/2005
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2000